Trial · NCT02299635
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events (SAEs) | PF-03084014 | Number of Participants with AEs | 18 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events (SAEs) | PF-03084014 | Number of Participants with SAEs | 6 | participants | |
| Number of Participants With Treatment-Emergent AEs by CTCAE Grade | PF-03084014 | Any AEs, Grade 1 | 1 | participants | |
| Number of Participants With Treatment-Emergent AEs by CTCAE Grade | PF-03084014 | Any AEs, Grade 2 | 5 | participants | |
| Number of Participants With Treatment-Emergent AEs by CTCAE Grade | PF-03084014 | Any AEs, Grade 3 | 9 | participants | |
| Number of Participants With Treatment-Emergent AEs by CTCAE Grade | PF-03084014 | Any AEs, Grade 4 | 1 | participants | |
| Number of Participants With Treatment-Emergent AEs by CTCAE Grade | PF-03084014 | Any AEs, Grade 5 | 2 | participants | |
| Number of Participants With Laboratory Test (Hematology) Abnormalities | PF-03084014 | Anemia | 12 | participants | |
| Number of Participants With Laboratory Test (Hematology) Abnormalities | PF-03084014 | Lymphocyte count increased | 0 | participants | |
| Number of Participants With Laboratory Test (Hematology) Abnormalities | PF-03084014 | Lymphopenia | 11 | participants | |
| Number of Participants With Laboratory Test (Hematology) Abnormalities | PF-03084014 | Neutrophils (absolute) | 0 | participants | |
| Number of Participants With Laboratory Test (Hematology) Abnormalities | PF-03084014 | Platelets | 3 | participants | |
| Number of Participants With Laboratory Test (Hematology) Abnormalities | PF-03084014 | White blood cells | 4 | participants | |
| Number of Participants With Laboratory Test (Chemistry) Abnormalities | PF-03084014 | Alanine aminotransferase | 5 | participants | |
| Number of Participants With Laboratory Test (Chemistry) Abnormalities | PF-03084014 | Alkaline phosphatase | 6 | participants | |
| Number of Participants With Laboratory Test (Chemistry) Abnormalities | PF-03084014 | Aspartate aminotransferase | 9 | participants | |
| Number of Participants With Laboratory Test (Chemistry) Abnormalities | PF-03084014 | Bilirubin (total) | 1 | participants | |
| Number of Participants With Laboratory Test (Chemistry) Abnormalities | PF-03084014 | Creatine kinase | 1 | participants | |
| Number of Participants With Laboratory Test (Chemistry) Abnormalities | PF-03084014 | Creatinine | 13 | participants | |
| Number of Participants With Laboratory Test (Chemistry) Abnormalities | PF-03084014 | Gamma glutamyl transferase | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02299635/results